# OnCo record paper-cll14-venetoclax-obinutuzumab-nejm-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-cll14-venetoclax-obinutuzumab-nejm-2019" ;
schema:name "CLL14: one year of venetoclax plus obinutuzumab instead of chemo-immunotherapy in older, less fit CLL patients"@en ;
schema:description "A fixed one-year course of two targeted drugs kept CLL under control far longer than chemo-immunotherapy, and most patients had no detectable disease when treatment stopped."@en ;
schema:url ;
schema:dateModified "2026-09-08"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2019"^^xsd:gYear ;
schema:author "Fischer K, Al-Sawaf O, Bahlo J, et al." ;
onco:related ;
onco:cancers ;
onco:targets , ;
onco:drugs , ;
onco:companies , ;
onco:terms , , , ;
onco:trials , ;
onco:people ;
onco:bottlenecks , ;
onco:journals .